The agreement adds Poland to their previous sales and distribution responsibilities for the Czech and Slovak Republics, and includes minimum purchase requirements. North Med distributes medical devices and capital equipment in all three countries, with special emphasis on neurosurgery, spine surgery, oncologic surgery, and orthopedic surgery.

Misonix said that the SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.

The SonicOne is an ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures. The SonicOne establishes a new standard in advanced wound care and ensures progress towards patient healing.

Michael McManus, president and chief executive officer of Misonix, said: “Misonix is pleased to partner with North Med, a high profile distributor of advanced medical equipment in the Czech and Slovak Republics, as well as Poland. Their commitment to quality and service, as well as their success in introducing high tech medical devices, has always appealed to Misonix. We are particularly pleased that they will be selling three of our key products through their well established distribution network.”